logo
Share SHARE
FONT-SIZE Plus   Neg

Novartis: Alcon Gets European CE Mark For Clareon IOL With AutonoMe

Novartis AG (NVS) announced Friday that its eye care unit Alcon has achieved European CE Mark for the Clareon IOL with the AutonoMe delivery system. Clareon AutonoMe is expected to be commercially available to cataract surgeons in the EU early next year.

AutonoMe is the first-and-only automated, disposable, pre-loaded IOL delivery system that enables precise delivery of the IOL into the capsular bag in patients undergoing cataract surgery.

The company said the new device is being introduced with the Clareon IOL, a new BioMaterial with an advanced design that enables sharp, crisp vision; low edge glare; and, unsurpassed optic clarity. These new innovations, along with supporting scientific data, will be presented at the XXXV congress of the European Society of Cataract & Refractive Surgeons (ESCRS) taking place October 7 - 11 in Lisbon, Portugal.

AutonoMe preloaded IOL delivery system provides easy, intuitive control for precise IOL insertion during cataract surgery.

Mike Ball, Chief Executive Officer, Alcon, said, "With the introduction of Clareon AutonoMe, we are proud to unveil our latest innovations to benefit doctors and their patients undergoing cataract surgery. … Clareon AutonoMe builds upon the comprehensive legacy of AcrySof by offering cataract surgeons easy, intuitive control of IOL delivery with the newest optic material."

The Clareon hydrophobic acrylic IOL, which received CE Mark in May, is made of a patented, innovative optic polymer material. Clareon builds on and maintains the benefits of the proven AcrySof platform with a new optic BioMaterial that offers cataract patients unsurpassed clarity.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Follow RTT